TWi Biotechnology (ROCO:6610) Marketable Securities: NT$1.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6610 TWi Biotechnology Inc ROCO:6610
34 GF Score
Price NT$28.90
! 2 Warning Signs
View Full Analysis

What is TWi Biotechnology Marketable Securities?

TWi Biotechnology ROCO:6610 +0.52% 34 Marketable Securities is NT$1.00 Mil as of Jun. 2026. GuruFocus rates ROCO:6610 with a GF Score™ of 34/100. The stock has 2 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. TWi Biotechnology's Marketable Securities for the quarter that ended in Jun. 2026 was NT$1.00 Mil.

TWi Biotechnology's annual Marketable Securities declined from Dec. 2023 (NT$171.85 Mil) to Dec. 2024 (NT$48.80 Mil) and declined from Dec. 2024 (NT$48.80 Mil) to Dec. 2025 (NT$0.00 Mil).

TWi Biotechnology  (ROCO:6610) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

TWi Biotechnology Marketable Securities Related Terms

TWi Biotechnology Marketable Securities Historical Data

* Premium members only.

The historical data trend for TWi Biotechnology's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TWi Biotechnology Marketable Securities Chart

TWi Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.30 0.00 171.85 48.80 0.00

TWi Biotechnology Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.13 48.80 0.00 0.00 1.00
ROCO:6610
34GF Score
TWi Biotechnology Inc ROCO:6610
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TWi Biotechnology Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of NT$1.00 Mil mean?
TWi Biotechnology (ROCO:6610) has a Marketable Securities of NT$1.00 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on TWi Biotechnology and its competitors.
Is TWi Biotechnology's Marketable Securities too high?
TWi Biotechnology's current Marketable Securities is NT$1.00 Mil. Overall, TWi Biotechnology has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does TWi Biotechnology's Marketable Securities compare to VRTX and REGN?
TWi Biotechnology's Marketable Securities of NT$1.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on TWi Biotechnology and its competitors. TWi Biotechnology's current Marketable Securities is NT$1.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TWi Biotechnology stock overvalued right now?
TWi Biotechnology (ROCO:6610) has a current Marketable Securities of NT$1.00 Mil. The current Marketable Securities is NT$1.00 Mil. TWi Biotechnology's overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For TWi Biotechnology (ROCO:6610), the current Marketable Securities is NT$1.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TWi Biotechnology Business Description

Address Lane 221, Kang Chien Road, 8th Floor, Number 41, Neihu District, Taipei, TWN, 11494
TWi Biotechnology Inc is a clinical-stage biopharmaceutical company based in Taiwan. It is engaged in the development of new drugs for unmet medical needs, particularly in the diseases associated with innate immunity. The pipeline products of the company comprise AC-201, AC-203, and AC-701.
34GF Score

Get the complete analysis for ROCO:6610

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$28.90
Price